Infanrix-IPV+Hib Description

After reconstitution, 1 dose (0.5 ml) contains: Diphtheria toxoid¹ not less than 30 International Units (IU) (25 Lf).
Tetanus toxoid¹ not less than 40 International Units (IU) (10 Lf).
Bordetella pertussis antigens: Pertussis toxoid (PT)¹ 25 micrograms; Filamentous haemagglutinin (FHA)¹ 25 micrograms; Pertactin (PRN)¹ 8 micrograms.
Poliovirus (inactivated) (IPV): type 1 (Mahoney strain)² 40 D-antigen unit; type 2 (MEF-1 strain)² 8 D-antigen unit; type 3 (Saukett strain)² 32 D-antigen unit.
Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) (PRP) 10 micrograms conjugated to tetanus toxoid as carrier protein approximately 25 micrograms.
¹ adsorbed on aluminium hydroxide, hydrated (Al(OH)₃) 0.5 milligrams Al³⁺.
² propagated in VERO cells.
The Infanrix-IPV component of the vaccine is a turbid white suspension. Upon storage, a white deposit and clear supernatant can be observed.
The Hib component of the vaccine is a white powder.
Excipients/Inactive Ingredients: Lactose; sodium chloride; Medium 199 (as stabilizer including amino acids, mineral salts and vitamins); water for injections. Potassium chloride; disodium phosphate; monopotassium phosphate; polysorbate 80; glycine; formaldehyde; neomycin sulphate; polymyxin sulphate are present as residuals from the manufacturing process.